2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Ethnic Barriers in Pediatric Liver Transplant Recipients. A Retrospective Study

M. Asolati,¹ T. Pillen,¹ R. Romero,² T. Heffron.¹
Etiology, Incidence and Outcomes of the Highly Sensitized Kidney Transplant Patient

R. Redfield, T. Zens, J. Scalea, M. Rizzari, D. Mandelbrot, D. Kaufman, A. Djamali.
European ELITA ELTR Multicenter Survey On the Management of Bile Duct During Liver Procurement, Preservation and Transplantation

N. Meurisse,¹ D. Monbaliu,¹ P. Muiesan,² A. Pascher,³ M. Oliverius,⁴ G. Berlakovich,⁵ R. Adam,⁶ I. Senesael,¹ J. Pirenne.¹
Evaluating Outcomes in Multi-Organ Liver Transplant Recipients

J. Snyder,¹ N. Salkowski,¹ D. Zaun,¹ B. Thompson,¹ J. Zeglin,¹ D. Schladt,¹ J. Lake,² W. Kim,³ A. Israni,¹ B. Kasiske.¹
Evaluating the Benefits of Everolimus on Cardiac Allograft Vasculopathy: Further Evidence from Results of Imputations for Missing IVUS Data from A2310 Study

P. Lopez,¹ G. Dong,² Z. Wang.²
Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients

L. Donohue, W. Ally, S. Dunn, J. Kennedy, J. Bergin.
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT

R. Bray,¹ H. Gebel,¹ R. Townsend,² U. Meier-Kriesche,² C. Larsen.¹
Evaluation of Geographically Distant Living Kidney Donors: A Barrier to Living Donation?

F. Weng, N. Dhillon, L. Davis, R. Goldberg, A. Patel, K. Tibaldi, M. Morgievich, S. Mulgaonkar.
Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy: A Single Center Experience

N. Nesselhauf,¹ J. Strutt,² B. Bastani.¹
Evaluation of Medication Regimen Complexity Over Time Following Heart Re-Transplantation

B. Bryant,¹ A. Libby,¹ R. Page,¹ J. Lindenfeld,² C. Aquilante.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z